{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:01Z","timestamp":1792090441359,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.spen.2025.101211","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:59:30Z","timestamp":1750939170000},"page":"101211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pediatric Neurocysticercosis. Burden of pediatric neurological disorders in resource-limited regions"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-3329","authenticated-orcid":false,"given":"Bolivar","family":"Quito-Betancourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cajas-Palomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Vides-Tesorero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Carpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.spen.2025.101211_bib0001","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(02)00454-1","article-title":"Neurocysticercosis: an update","volume":"2","author":"Carpio","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.spen.2025.101211_bib0002","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s13312-021-2311-6","article-title":"Management of neurocysticercosis in children: association of Child Neurology Consensus Guidelines","volume":"58","author":"Sankhyan","year":"2021","journal-title":"Indian Pediatr"},{"issue":"8","key":"10.1016\/j.spen.2025.101211_bib0003","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/cid\/cix1084","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"White","year":"2018","journal-title":"Clinic Infect Dis"},{"issue":"11","key":"10.1016\/j.spen.2025.101211_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010870","article-title":"Characteristics of people with epilepsy and neurocysticercosis in three eastern African countries\u2013A pooled analysis","volume":"16","author":"Stelzle","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.spen.2025.101211_bib0005","article-title":"Correction to: Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe","year":"2023","journal-title":"J Travel Med."},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00085-19","article-title":"Taenia solium cysticercosis and its impact on neurological disease","volume":"33","author":"Garcia","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011042","article-title":"The epidemiology of human Taenia solium infections: a systematic review of the distribution in Eastern and Southern Africa","volume":"17","author":"Zulu","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.spen.2025.101211_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1077723","article-title":"Prevalence trend and burden of neglected parasitic diseases in China from 1990 to 2019: findings from global burden of disease study","volume":"11","author":"Xie","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.spen.2025.101211_bib0009","doi-asserted-by":"crossref","unstructured":"Dixon M.A., Winskill P., Harrison W.E, Bas\u00e1\u00f1ez MG. Taenia solium taeniasis\/cysticercosis: from parasite biology and immunology to diagnosis and control. In:; 2021:133-217. doi:10.1016\/bs.apar.2021.03.003.","DOI":"10.1016\/bs.apar.2021.03.003"},{"key":"10.1016\/j.spen.2025.101211_bib0010","unstructured":"Centers for Disease Control. Centers for Disease Control and Prevention. DPDx: cysticercosis. https:\/\/www.cdc.gov\/dpdx\/cysticercosis\/index.html."},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0011","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1371\/journal.pntd.0000371","article-title":"Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on Human seroprevalence but not on seizures","volume":"3","author":"Lescano","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0004-282X2007000100019","article-title":"Anatomopathological aspects of neurocysticercosis in autopsied patients","volume":"65","author":"Lino-Junior","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0013","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0031182015001572","article-title":"Cellular immune response in intraventricular experimental neurocysticercosis","volume":"143","author":"Moura","year":"2016","journal-title":"Parasitology"},{"issue":"12","key":"10.1016\/j.spen.2025.101211_bib0014","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-3024.2007.00967.x","article-title":"The immune response in Taenia solium cysticercosis: protection and injury","volume":"29","author":"Sciutto","year":"2007","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/pim.12299","article-title":"Immunopathology in Taenia solium neurocysticercosis","volume":"38","author":"Fleury","year":"2016","journal-title":"Parasite Immunol"},{"issue":"4","key":"10.1016\/j.spen.2025.101211_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008005","article-title":"Host immune responses during Taenia solium Neurocysticercosis infection and treatment","volume":"14","author":"Prodjinotho","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.spen.2025.101211_bib0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2023.04.005","article-title":"Neurocysticercosis-related seizures: imaging biomarkers","volume":"108","author":"Ratcliffe","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2025.101211_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117527","article-title":"A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world","volume":"427","author":"Bustos","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2025.101211_bib0026","article-title":"Mesencephalic neurocysticercosis","volume":"45","author":"OJ","year":"2022","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"10.1016\/j.spen.2025.101211_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/088307380001500401","article-title":"Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy","volume":"15","author":"Singhi","year":"2000","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MD.0b013e318206d13e","article-title":"Neurocysticercosis in Houston, Texas","volume":"90","author":"Serpa","year":"2011","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12098-017-2460-8","article-title":"Pediatric neurocysticercosis","volume":"86","author":"Singhi","year":"2019","journal-title":"Ind J Pediatrics"},{"issue":"11","key":"10.1016\/j.spen.2025.101211_bib0023","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/pathogens12111313","article-title":"Clinical characteristics of neurocysticercosis in a Peruvian population-based epilepsy cohort: a descriptive cross-sectional study of baseline Clinical intake","volume":"12","author":"Allen","year":"2023","journal-title":"Pathogens"},{"issue":"02","key":"10.1016\/j.spen.2025.101211_bib0024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0034-1399753","article-title":"Pediatric neurocysticercosis: three cases presented in the Netherlands with divergent clinical presentations","volume":"46","author":"Van De Pol","year":"2015","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.spen.2025.101211_bib0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4103\/mjdrdypu.mjdrdypu_235_22","article-title":"Case series on the clinical profile of neurocysticercosis in pediatric age group","volume":"15","author":"Chalipat","year":"2022","journal-title":"Med J Dr DY Patil Vidyapeeth"},{"issue":"2","key":"10.1016\/j.spen.2025.101211_bib0027","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jrid.2014.12.001","article-title":"Imaging spectrum of neurocysticercosis","volume":"1","author":"Zhao","year":"2015","journal-title":"Radiol Infect Dis"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0028","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1985.00360030074016","article-title":"Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases","volume":"145","author":"Sotelo","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.spen.2025.101211_bib0029","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yebeh.2017.02.030","article-title":"Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy","volume":"76","author":"Bianchin","year":"2017","journal-title":"Epilepsy Behavior"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4269\/ajtmh.21-0392","article-title":"Hippocampal atrophy\/sclerosis is associated with old, calcified parenchymal brain neurocysticercosis, but not with more recent, viable infections","volume":"106","author":"S\u00e1nchez","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.spen.2025.101211_bib0031","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.33931","article-title":"Cysticercal encephalitis in a young female: a rare presentation of neurocysticercosis","author":"Ikeogu","year":"2023","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.spen.2025.101211_bib0032","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s10072-023-06810-z","article-title":"Intraventricular neurocysticercosis: a correlative radiopathological image","volume":"44","author":"Mansour","year":"2023","journal-title":"Neurologic Sci"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0033","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13760-017-0831-6","article-title":"Caught in the act: migrating intraventricular neurocysticercosis causing intermittent unilateral hydrocephalus due to foramen of Monro obstruction","volume":"118","author":"Rana","year":"2018","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/17460913.2024.2428526","article-title":"Treatment outcome in patients with spinal neurocysticercosis: a systematic review of published cases and case series","volume":"20","author":"Garg","year":"2025","journal-title":"Future Microbiol"},{"issue":"10","key":"10.1016\/j.spen.2025.101211_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3941\/jrcr.v16i10.4543","article-title":"Isolated spinal cord neurocysticercosis","volume":"16","author":"Kus","year":"2022","journal-title":"J Radiol Case Rep"},{"issue":"7","key":"10.1016\/j.spen.2025.101211_bib0036","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2016.09.003","article-title":"Disease centered around calcified taenia solium granuloma","volume":"33","author":"Nash","year":"2017","journal-title":"Trends Parasitol"},{"issue":"4","key":"10.1016\/j.spen.2025.101211_bib0038","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4269\/ajtmh.19-0278","article-title":"An ambispective cohort study to assess seizure recurrences in children with calcified parenchymal neurocysticercosis","volume":"101","author":"Modak","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.spen.2025.101211_bib0039","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","volume":"2021","author":"Walton","year":"2021","journal-title":"Cochrane Data Syst Rev"},{"issue":"9","key":"10.1016\/j.spen.2025.101211_bib0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"J Neurol Neurosurg Psychiat"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0041","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1573396320666230508150342","article-title":"Distinctive clinico-electrographic and radiological profile of childhood and adolescent seizures","volume":"20","author":"Prabha","year":"2024","journal-title":"Curr Pediatr Rev"},{"issue":"7","key":"10.1016\/j.spen.2025.101211_bib0042","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.eplepsyres.2014.04.013","article-title":"Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis","volume":"108","author":"Gulati","year":"2014","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.spen.2025.101211_bib0043","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/20477724.2021.2015869","article-title":"Neurocysticercosis control for primary epilepsy prevention: a systematic review","volume":"116","author":"Wang","year":"2022","journal-title":"Pathog Glob Health"},{"issue":"7","key":"10.1016\/j.spen.2025.101211_bib0044","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/08830738211047018","article-title":"Location of lesion on neuroimaging, and interictal electroencephalographic (EEG) abnormalities in children with single-lesion neurocysticercosis\u2014Is there a correlation?","volume":"37","author":"Srinivasan","year":"2022","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tmi.13010","article-title":"Low sensitivity and frequent cross-reactions in commercially available antibody detection <scp>ELISA<\/scp>assays for Taenia solium cysticercosis","volume":"23","author":"Garcia","year":"2018","journal-title":"Tropic Med Int Health"},{"issue":"40","key":"10.1016\/j.spen.2025.101211_bib0046","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.40.1700709","article-title":"Screening for neurocysticercosis in internationally adopted children: yield, cost and performance of serological tests, Italy, 2001 to 2016","volume":"23","author":"Zammarchi","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.spen.2025.101211_bib0047","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","article-title":"Revised diagnostic criteria for neurocysticercosis","volume":"372","author":"Del Brutto","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2025.101211_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fpara.2024.1394089","article-title":"From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis","volume":"3","author":"Toribio","year":"2024","journal-title":"Frontiers Parasitol"},{"issue":"9","key":"10.1016\/j.spen.2025.101211_bib0049","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/cid\/ciz543","article-title":"Diagnosis and management of neurocysticercosis: will real-time polymerase chain reaction help?","volume":"70","author":"White","year":"2020","journal-title":"Clinic Infectious Dis"},{"key":"10.1016\/j.spen.2025.101211_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107139","article-title":"An update on neurocysticercosis-related epilepsy","volume":"213","author":"Espino","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.spen.2025.101211_bib0052","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.64617","article-title":"Effectiveness of the antiparasitic combination of Albendazole and Praziquantel As compared with albendazole monotherapy in the treatment of neurocysticercosis in children: a systematic review and meta-analysis","author":"Dewi","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.spen.2025.101211_bib0053","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/epi.16302","article-title":"Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis","volume":"60","author":"Carpio","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2025.101211_bib0054","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s13312-022-2662-7","article-title":"Fourteen days vs 28 days of albendazole therapy for neurocysticercosis in children: an open label randomized controlled trial","volume":"12","author":"Singla","year":"2022","journal-title":"Indian Pediatr"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0056","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"New Eng J Med"},{"issue":"1","key":"10.1016\/j.spen.2025.101211_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13010026","article-title":"Calcified neurocysticercosis: demographic, clinical, and radiological characteristics of a large hospital-based patient cohort","volume":"13","author":"Bustos","year":"2024","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.spen.2025.101211_bib0058","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(08)70243-6","article-title":"Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case\u2013control study","volume":"7","author":"Nash","year":"2008","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.spen.2025.101211_bib0059","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0883073818766985","article-title":"Long-term cognitive outcome of children with parenchymal neurocysticercosis: a prospective observation study","volume":"33","author":"Singhi","year":"2018","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2025.101211_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.seizure.2021.02.019","article-title":"New understanding about the relationship among neurocysticercosis, seizures, and epilepsy","volume":"90","author":"Carpio","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.spen.2025.101211_bib0061","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.seizure.2010.10.036","article-title":"Seizure in people with newly diagnosed active or transitional neurocysticercosis","volume":"20","author":"Kelvin","year":"2011","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0062","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmac032","article-title":"Comparative efficacy and safety of lacosamide and oxcarbazepine for seizure control in children with newly diagnosed solitary neurocysticercosis","volume":"68","author":"Sharawat","year":"2022","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.spen.2025.101211_bib0063","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ane.13355","article-title":"Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis","volume":"143","author":"Santhosh","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.spen.2025.101211_bib0064","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12098-024-05140-y","article-title":"Etanercept: a potential option in refractory complicated neurocysticercosis","volume":"91","author":"Lokesh","year":"2024","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.spen.2025.101211_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vetpar.2016.05.029","article-title":"Why pigs are free-roaming: communities\u2019 perceptions, knowledge and practices regarding pig management and taeniosis\/cysticercosis in a Taenia solium endemic rural area in Eastern Zambia","volume":"225","author":"Thys","year":"2016","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.spen.2025.101211_bib0066","article-title":"Mass chemotherapy with niclosamide for the control of taenia solium: population-based safety profile and treatment effectiveness","volume":"38","author":"Wardle","year":"2024","journal-title":"Lancet Region Health - Am"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909125000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909125000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:25:33Z","timestamp":1753125933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909125000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":63,"alternative-id":["S1071909125000324"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2025.101211","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Neurocysticercosis. Burden of pediatric neurological disorders in resource-limited regions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2025.101211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101211"}}